Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP By Ogkologos - September 22, 2026 81 0 Facebook Twitter Google+ Pinterest WhatsApp Updated results after additional follow-up in the CUPISCO study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Epigenetic Changes Pinpointed as the Cause of Some GISTs November 19, 2019 NHL Player Carey Price Surprises 11-Year-Old Boy Who Just Lost Mom... June 24, 2019 FDA Proposes Rule Prohibiting Menthol Cigarettes June 27, 2022 No OS Benefit for Active Maintenance Treatment with Olaparib Relative to... July 22, 2022 Load more HOT NEWS Ground-breaking trial pilots new tests to detect lung cancer earlier ESMO welcomes the adoption of European Parliament Report on Europe’s Beating... Lo que deben saber las personas con cáncer de mama y... When You Have to Make Decisions for a Loved One With...
